Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
BLOG
Read on
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
While many biopharmaceutical companies are built to fulfil a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
Master Cell Banks: Laying the Foundation to Final Product Success
Consider our top 5 FAQs when it comes to MCBs Master cell banks (MCBs) are a critical starting material that lay the foundation for the scale-up and...
Looking Ahead: What Does the Future Have in Store for Nucleic Acid-Based Therapies?
A Q&A with Aaron Larsen Aaron Larsen is the Technical Head for the Nucleic Acids Franchise with Resilience. He began working with nucleic acids back...
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company
SAN DIEGO, CA, February 16, 2023 – National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access...
How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and Siemens
Resilience is thrilled to participate in a joint webinar, “How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and...
Alachua Biomanufacturing Expansion Video
We are remaking the way medicines are made and that starts with our facilities. At our Alachua, Florida campus, Building G defines the future of our...
Resilience Announces Equity Investment from Mubadala and Funding of New Biopharma Manufacturing Facility in the United Arab Emirates
SAN DIEGO--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to...
